Byam Rebecca's Form 4/A amendment
AmendedHCW Biologics Inc. (HCWB) · filed Sep 10, 2021
- Accession no.
- 0001209191-21-055532
- Filed
- Sep 10, 2021
- Trade date
- Aug 19, 2021
- Filing delay
- 22 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Aug 23, 2021
This filing lists 1 non-derivative transaction. Open-market purchases total $44.0K. It was filed 22 days after the trade.
This amendment replaces 0001209191-21-053049 (filed Aug 23, 2021).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Byam RebeccaCIK 0001866256 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2021 | Common Stock | PPurchaseAcquired | +10,000 | $4.40F1 | +$44,000 | 62,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The range of prices for the shares of Common Stock is from $4.17 to $4.68. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
Remarks
The purpose of this amendment to the Form 4 filed on August 23, 2021 is to add a footnote disclosing the range of the prices for the shares bought on that day.